Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
出版年份 2008 全文链接
标题
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
作者
关键词
-
出版物
CLINICAL INFECTIOUS DISEASES
Volume 48, Issue 1, Pages 1-12
出版商
Oxford University Press (OUP)
发表日期
2008-11-27
DOI
10.1086/595011
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Position Paper: Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Community‐Acquired Pneumonia
- (2008) CLINICAL INFECTIOUS DISEASES
- Executive Summary: Workshop on Issues in the Design and Conduct of Clinical Trials of Antibacterial Drugs in the Treatment of Community‐Acquired Pneumonia
- (2008) Brad Spellberg et al. CLINICAL INFECTIOUS DISEASES
- A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005
- (2008) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Superantigen Profile ofStaphylococcus aureusIsolates from Patients with Steroid‐Resistant Atopic Dermatitis
- (2008) Patrick M. Schlievert et al. CLINICAL INFECTIOUS DISEASES
- Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus
- (2008) Martin E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections
- (2008) G. J. Noel et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem‐ResistantEscherichia coliHarboringKlebsiella pneumoniaeCarbapenemase β‐Lactamases Associated with Long‐Term Care Facilities
- (2008) Carl Urban et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options
- (2008) Lisa L. Maragakis et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology of Methicillin‐ResistantStaphylococcus aureus
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms
- (2008) Martin E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- “The truth, if it exists, is in the details”*
- (2008) David Gilbert CRITICAL CARE MEDICINE
- What is in the pipeline for Gram-negative pathogens?
- (2008) George H Talbot Expert Review of Anti-Infective Therapy
- Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria
- (2008) Vicente Pintado et al. JOURNAL OF INFECTION
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
- (2008) Louis B. Rice JOURNAL OF INFECTIOUS DISEASES
- Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement
- (2008) Ian Chopra et al. LANCET INFECTIOUS DISEASES
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
- Trends in disease focus of drug development
- (2008) Johan P. E. Karlberg NATURE REVIEWS DRUG DISCOVERY
- Acinetobacter Infection
- (2008) L. Silvia Munoz-Price et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Bacteria Fight Back
- (2008) G. Taubes SCIENCE
- The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
- (2007) B. Spellberg et al. CLINICAL INFECTIOUS DISEASES
- Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia
- (2007) K. M. Erlandson et al. CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started